V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320006554 | 320003845 | null | 62.3 | Palliative (P) | 2015-03-15 | 2015-03-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320020198 | EOX |
| 320006555 | 320003848 | 1.65 | 0 | Palliative (P) | 2015-05-04 | 2015-06-03 | CNS GCT II Germinoma - Carbo Etop | N | N | 320020274 | ETOPOSIDE |
| 320006556 | 320003850 | 1.65 | 84 | Palliative (P) | 2016-11-28 | 2016-12-04 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 320020277 | NIVOLUMAB |
| 320006557 | 320003853 | 1.71 | 100 | Palliative (P) | 2015-12-03 | 2016-05-15 | Bevacizumab + CAPECITABINE + OXALIPLATIN | Y | null | 320020281 | BCG |
| 320006558 | 320003858 | 1.63 | 59 | Palliative (P) | 2017-07-06 | 2018-01-18 | Doxorubicin 75mg/m2 | N | N | 320020343 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320006559 | 320003863 | 1.62 | 99.2 | Adjuvant (A) | 2015-12-30 | 2016-06-23 | Cetuximab+Cisplatin+FU (> Cycle 2) | Y | Y | 320020395 | EVEROLIMUS |
| 320006560 | 320003864 | 1.87 | null | null | 2017-10-12 | 2017-10-14 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 320020416 | TCF |
| 320006561 | 320003869 | 1.6 | null | Palliative (P) | 2014-08-09 | 2014-08-09 | Docetaxel | Y | N | 320020419 | CARBOPLATIN + ETOPOSIDE |
| 320006562 | 320003871 | 1.68 | 37.05 | Palliative (P) | 2017-08-09 | 2017-08-23 | BEVACIZUMAB + CARBO + PACLITAXEL | N | Y | 320020423 | RMS 2005 TRIAL |
| 320006563 | 320005769 | 1.51 | 55.8 | Disease modification (D) | 2016-08-19 | 2016-12-04 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 320020504 | CARBOPLATIN + RT |
| 320006564 | 320003876 | 1.7 | 35.8 | Palliative (P) | 2018-02-05 | 2018-02-17 | IVADo | N | N | 320020549 | ECX |
| 320006565 | 320003877 | 1.86 | 53.3 | Palliative (P) | 2013-12-31 | 2014-01-01 | Vemurafenib | Y | Y | 320020550 | CISPLATIN + GEMCITABINE |
| 320006568 | 320005773 | 1.54 | 64.7 | Adjuvant (A) | 2015-04-16 | 2015-04-16 | ETOPOSIDE | 2 | N | 320020652 | TOPOTECAN |
| 320006569 | 320003885 | 1.7 | 87 | null | 2014-02-28 | 2014-03-26 | CHOP R - 21 days | N | N | 320020709 | RITUXIMAB |
| 320006570 | 320003890 | 1.6 | 85 | Adjuvant (A) | 2016-05-27 | 2016-05-27 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 320020718 | ATEZOLIZUMAB |
| 320006571 | 320003893 | 1.85 | null | Palliative (P) | 2018-11-21 | 2018-11-29 | Capecitabine (14 days)+Carboplatin | 02 | N | 320020748 | CAPECITABINE + OXALIPLATIN |
| 320006572 | 320003895 | 1.67 | 98 | null | 2015-05-11 | 2015-06-13 | ICON8B TRIAL | N | null | 320020758 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 320006574 | 320003900 | null | null | Adjuvant (A) | 2013-05-04 | 2013-05-04 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 320020976 | TEMOZOLOMIDE + RT |
| 320006575 | 320003904 | 1.62 | 103 | Palliative (P) | 2014-08-15 | 2015-04-03 | IMATINIB | 02 | N | 320021009 | LOMUSTINE + PROCARBAZINE |
| 320006576 | 320003906 | 0 | null | Curative (C) | 2014-09-13 | 2014-09-13 | CAPECITABINE + OXALIPLATIN | null | null | 320021011 | CISPLATIN + GEMCITABINE |
| 320006578 | 320003912 | null | 63 | Palliative (P) | 2018-08-01 | 2018-08-01 | TEMOZOLOMIDE | 2 | Y | 320021098 | BCG |
| 320006579 | 320003913 | 1.87 | 67 | Adjuvant (A) | 2018-03-04 | 2018-03-04 | Cetuximab + Radiotherapy Maint | N | N | 320021106 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320006580 | 320007110 | 1.76 | null | Curative (C) | 2013-04-04 | 2013-09-10 | CNS LGG 2004 03 vinc weekly+ carbo | N | null | 320022673 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320006581 | 320003914 | 1.68 | 80 | Palliative (P) | 2014-12-15 | 2015-02-10 | CARBOPLATIN + CETUXIMAB + FU | 02 | N | 320022701 | CARBOPLATIN + CETUXIMAB + FU |
| 320006582 | 320005788 | 1.66 | 76.1 | null | 2016-01-31 | 2016-07-09 | NIVOLUMAB | N | null | 320022738 | GEMCITABINE |
| 320006583 | 320003917 | 1.85 | 72.4 | Palliative (P) | 2016-04-19 | 2016-04-30 | Atezolizumab | 2 | N | 320022743 | IVADO |
| 320006584 | 320003919 | 1.87 | 81.2 | Palliative (P) | 2014-12-07 | 2015-01-05 | CETUXIMAB + RT | N | N | 320022758 | CAPECITABINE + CISPLATIN + EPIRUBICIN |
| 320006585 | 320003921 | 1.77 | 103 | Curative (C) | 2018-06-17 | 2018-09-08 | EOX | N | null | 320022766 | IVA |
| 320006586 | 320003922 | 1.74 | null | Adjuvant (A) | 2017-08-03 | 2017-08-04 | Ipilimumab | 02 | N | 320022776 | PEMBROLIZUMAB |
| 320006587 | 320003924 | 1.6 | 109.1 | Neo-adjuvant (N) | 2013-08-23 | 2013-08-23 | ECX | 02 | N | 320022797 | CARBO + FLUOROURACIL |
| 320006588 | 320003926 | 1.7 | 80.9 | Curative (C) | 2018-12-22 | 2018-12-24 | ECarboX | 2 | N | 320022811 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320006589 | 320003929 | 1.83 | 116 | Unknown (U) | 2018-05-23 | 2018-08-06 | Ipilimumab | N | N | 320022821 | PEMETREXED |
| 320006590 | 320003933 | 1.78 | null | Palliative (P) | 2014-03-12 | 2014-03-13 | Etoposide + Ifosfamide (3 days) | 2 | Y | 320022835 | TEMOZOLOMIDE |
| 320006591 | 320003935 | 1.54 | 59.3 | Curative (C) | 2014-12-18 | 2014-12-25 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 320022860 | POUT TRIAL |
| 320006592 | 320003936 | 1.64 | 103.3 | Disease modification (D) | 2013-05-29 | 2013-08-07 | IPILIMUMAB + NIVOLUMAB | N | N | 320022861 | CARBOPLATIN + RT |
| 320006593 | 320003938 | 1.62 | 46 | Palliative (P) | 2018-02-25 | 2018-03-05 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 320022868 | ETOPOSIDE |
| 320006594 | 320003940 | 1.68 | 61.6 | Adjuvant (A) | 2014-01-23 | 2016-02-08 | Gemcitabine weekly | N | N | 320022881 | DOCETAXEL |
| 320006595 | 320005803 | 1.87 | 73.8 | Adjuvant (A) | 2016-05-08 | 2016-05-19 | NIVOLUMAB | 02 | N | 320022903 | TEMOZOLOMIDE |
| 320006597 | 320003945 | 1.81 | null | Palliative (P) | 2018-01-08 | 2018-01-09 | POUT TRIAL | N | N | 320022984 | CARBOPLATIN + RT |
| 320006598 | 320003948 | 1.65 | null | Curative (C) | 2015-03-17 | 2015-03-18 | Irinotecan + Temozolomide | N | N | 320023007 | CARBO + FLUOROURACIL |
| 320006599 | 320005808 | 1.73 | 60 | Palliative (P) | 2018-06-17 | 2018-07-03 | ECX | N | N | 320023057 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320006600 | 320003952 | 1.83 | 68.3 | Curative (C) | 2018-07-19 | 2018-07-19 | Imatinib 400mg | 2 | N | 320023065 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 320006601 | 320003954 | 1.77 | 71.4 | Palliative (P) | 2014-02-18 | 2014-05-10 | Carboplatin + Docetaxel | N | N | 320023097 | IMATINIB |
| 320006602 | 320003958 | 1.67 | 68.8 | Palliative (P) | 2015-08-24 | 2015-09-14 | ICON8 TRIAL | 02 | N | 320023133 | CETUXIMAB + RT |
| 320006603 | 320003961 | 1.61 | 21 | Palliative (P) | 2013-09-09 | 2013-09-09 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 320023140 | TEMOZOLOMIDE |
| 320006604 | 320003962 | 1.68 | 88 | Neo-adjuvant (N) | 2015-03-19 | 2015-04-03 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 320023140 | CISPLATIN + GEMCITABINE |
| 320006605 | 320003966 | 1.74 | 60.8 | Palliative (P) | 2016-11-29 | 2016-12-20 | Carboplatin + Cetux + FU (Cycle 1) | Y | null | 320023162 | CARBOPLATIN + RT |
| 320006606 | 320003967 | 1.77 | 58 | Palliative (P) | 2018-03-18 | 2018-11-02 | NIVOLUMAB | 2 | N | 320023192 | CETUXIMAB + RT |
| 320006607 | 320003970 | 1.76 | 53 | Palliative (P) | 2017-04-26 | 2017-04-26 | Abiraterone | N | Y | 320023192 | CAPECITABINE + OXALIPLATIN |
| 320006608 | 320003974 | 1.49 | 76 | Palliative (P) | 2016-11-08 | 2016-12-14 | CAPECITABINE + IRINOTECAN | N | N | 320023207 | RMS 2005 TRIAL |